Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs
Breakthrough gene therapy fidanacogene elaparvovec shows long-term efficacy in treating hemophilia B with a single dose, potentially curing this genetic bleeding disorder.